# Terra Magnum Capital Partners

Terra Magnum Capital Partners is a Private Equity based in Beijing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** www.terramagnumcap.com
- **LinkedIn:** https://www.linkedin.com/company/terra-magnum

## Regulatory record

- **Reports private funds:** No

## About

Terra Magnum Capital Partners is a China-focused private equity firm with over $800 million in assets under management. The firm has made 12 investments, including a Series C investment in Iambic Therapeutics on November 10, 2025. Terra Magnum Capital Partners has also achieved 8 portfolio exits, with Maze Therapeutics being its most recent exit on January 31, 2025.

## Questions

### What investment stages does Terra Magnum Capital Partners target?

The firm targets a broad range: seed, start-up, early-stage venture, growth, expansion, and PIPE transactions. This full-lifecycle approach allows Terra Magnum to deploy capital from initial formation rounds through to pre-IPO placements. The multi-stage mandate is structured to retain exposure to portfolio companies as they mature, rather than exiting at a single inflection point.

## Related profiles

- [Terrain Capital Management](https://altss.com/profile/terrain-capital-management)
- [TerraMar Capital](https://altss.com/profile/terramar-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/terra-magnum-capital-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology